ZYME - Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript

2024-05-02 20:04:10 ET

Zymeworks Inc. (ZYME)

Q1 2024 Earnings Call Transcript

May 02, 2024 04:30 PM ET

Company Participants

Shrinal Inamdar - Director, Investor Relations

Ken Galbraith - Chair and CEO

Paul Moore - Chief Scientific Officer

Conference Call Participants

Stephen Willey - Stifel

Ashiq Mubarack - city

Ivy Wang - Jefferies

Brian Cheng - JPMorgan

Jon Miller - Evercore ISI

Presentation

Operator

Thank you for standing by. This is the conference operator. Welcome to Zymeworks First Quarter 2024 Results Conference Call and Webcast. As a reminder, all participants are in a listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. [Operator Instructions].

I would now like to turn the conference over to Shrinal Inamdar, Director of Investor Relations. Shrinal, please go ahead.

Shrinal Inamdar

Thank you, Operator. Good afternoon. I’d like to welcome you all to our first quarter 2024 results conference call. Before we begin, I’d like to remind you that we’ll be making a number of forward-looking statements during this call, including without limitation, those forward-looking statements identified in our presentation slides and the accompanying oral commentary.

Forward-looking statements are based upon our current expectations and various assumptions, and are subject to the usual risks and uncertainties associated with companies in our industry and at our stage of development. For discussion of these risks and uncertainties, we refer you to our latest SEC filings as found on our website and as part of the SEC.

In a moment, I’ll hand over to Ken Galbraith, our Chair and Chief Executive Officer, who will be discussing recent scientific and corporate updates, along with our financial results for the first quarter 2024. Following this, Dr. Paul Moore, our Chief Scientific Officer, will talk about recent data shared at the Annual American Association for Cancer Research or AACR meeting and key takeaways. At the end of the call, Ken, Paul and Bijal Desai, our VP of Finance and Strategy, will be available for Q&A. ...

For further details see: